A/Prof Rene Stolwyk is an Associate Professor and Clinical Neuropsychologist at the Turner Institute for Brain and Mental Health at Monash University in Melbourne, Australia. A passionate scientist-practitioner, A/Prof Stolwyk enjoys working at the nexus of research, clinical practice and clinical education.
From a research perspective, A/Prof Stolwyk leads Stroke and Telehealth research within the Monash-Epworth Rehabilitation Research Centre. He supervises a team of 12 research fellows, research officers and doctoral students and has published over 70 scientific works aimed at improving cognitive and mood outcomes for survivors of brain injury. He is the founder and clinical lead of the Monash TeleNeuropsychology Service, a world first initiative using digital health technology to facilitate access to much-needed neuropsychological assessment and rehabilitation services to rural neurology patients throughout Australia.
A/Prof Stolwyk is also convenor of the Clinical PhD (Clinical Neuropsychology) training program at Monash University. He leads a team of highly-skilled educators providing excellence in clinical training to the next generation of Australian neuropsychologists.

Associate Professor Carmela Pestell is a clinician, lecturer and researcher based at the Robin Winkler Clinic (School of Psychological Science) UWA. She has worked as a clinical psychologist and neuropsychologist for more than 24 years. Associate Professor Pestell’s experience as a clinician has led to her current research interests in Foetal Alcohol Spectrum Disorder (FASD. Dr Pestell was the lead neuropsychologist on the Banksia Hill Detention Centre Study investigating the prevalence of FASD in youth detention. Dr Pestell was also the co-recipient of a Commonwealth grant to educate health professionals in diagnosing FASD. This involved setting up FASD clinics in the Northern Territory, Tasmania and South Australia. She had input into the Australian Diagnostic Guidelines for FASD and is now on a national working group that is reviewing these diagnostic guidelines. As a leading researcher into FASD, her work has taken her to clinics in remote locations of Western Australia and the Northern Territory. Dr Pestell co-led the development of a new Graduate Certificate in the Assessment and Diagnosis of FASD at UWA from 2019 and more recently, microcredential units in FASD. She is an invited expert on commonwealth government FASD advisory committees and an invited ambassador for NoFASD

Dr Fiona Chan is a neurologist specialising in Neuro-Ophthalmology and Neuro-Immunology. She completed her neurology training in Australia before undertaking a Neuro-Ophthalmology fellowship in the United Kingdom. She was subsequently employed as a Neuro-Ophthalmology Consultant at the Queen Elizabeth Hospital in Birmingham which functions as one of Europe’s largest Neuro-Ophthalmology departments.

In addition, she has subspecialty training in Neuro-Immunology and was the first Australian to be awarded a highly competitive clinical research scholarship by the European Committee for Treatment in Multiple Sclerosis (ECTRIMS). This scholarship enabled her clinical research at the University of Oxford, where she focused on advancing the management of patients at the Neuro-Ophthalmology and Neuro-Immunology interface.

Her academic work has resulted in multiple research article publications and speaking invitations in international conferences. She continues to be actively engaged in research and is currently undertaking a PhD in neuro-immunological conditions and their impact on the visual system.

Rosie is an experienced General Practitioner and former medical educator for James Cook University Generalist Medical Training. She supervises GP registrars and medical students. I have been a rural GP for 30 years and have encountered many cases of Q fever in that time and been involved with the mass vaccination clinics in the 90s as well as running vaccination clinics through the medical centre for many years.

Dr. Adele Hosseini has over 18 years’ experience leading the delivery of successful clinical trials including first in human pharmaceuticals and medical devices. Dr. Hosseini has also been involved in many aspects of healthcare including academia such as university lecturing, product development within pharmaceutical, biotech, medical device. She is a pioneer in the Australian medicinal cannabis industry-leading Bod Australia’s Scientific Advisory Board and research program. Over the last three years Dr. Hosseini has developed a deep understanding of medicinal cannabis and continues the strategic direction and development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications.

Dr. Jacqueline Anderson is a Senior Lecturer in Clinical Neuropsychology in the Melbourne School of Psychological Sciences; she is also the Convenor of the School’s Postgraduate Program in Clinical Neuropsychology. As well as undertaking research in the area of concussion, she has 20 years of experience working as a Clinical Neuropsychologist in both the public and private health sectors.

Rebecca works as a Perinatal Psychiatrist in London, dealing with infertility, pregnancy loss, anxiety, depression, OCD and trauma. She’s got experience spanning over twenty years. She developed a particular interest in birth trauma, which led to founding the annual Birth Trauma Conference and Make Birth Better with Emma in 2018.

I have the luxury of working with women all through their pregnancies and beyond. I personally had a really tough pregnancy with hyperemesis, a huge risk factor for birth trauma. And there was a real lack of kindness in my birth. I passionately believe that many of the most important skills are being lost in medicine due to the pressures on the system and burnt out medical staff. I believe that kindness, time and dignity matter very much. What we are building at Make Birth Better is a powerful collective of amazing parents and professionals. We are all equal in this. Together, we must be loud and bold. Birth can, and must be, better. No second best. No excuses. 

As QLD State Practice Group Leader for Slater and Gordon I seek to provide my clients with a clear and effective path through the legal system that delivers the best outcome for their case. I am currently based in the Brisbane Office but manage cases QLD wide.
In the past I have worked in diverse areas of medical malpractice in London and Australia, and for the last ten years’ as a specialist litigation lawyer.
When I work on your case, I utilise more than 20 years’ legal and case knowledge to deeply understand your circumstances, the options for moving forward, and the best strategy for delivering a positive outcome for you and your family. I help you navigate a complex legal system, providing you with knowledge of progress and timeframes. My goal is to remove any potential for additional stress during what can be a challenging period in your life.
As Practice Leader with Slater and Gordon QLD, I am motivated every day by the knowledge I am making a positive impact on my clients’ lives. It is a rewarding experience to help those who have suffered an unexpected loss and providing them with a voice they wouldn’t otherwise have had.
I have firsthand knowledge of the of the challenges and upheaval caused by a life-changing incident for my clients and their families. My goal is to provide an empathetic and supportive approach. I am familiar with the emotional and physical needs of people who are experiencing a difficult time in their life and the legal knowledge to help them get back on track.

Honorary Professorial Fellow
Melbourne School of Psychological Sciences
Faculty of Medicine, Dentistry, and Health Sciences
The University of Melbourne Victoria 3008

Dr Bronwyn Devine is a fertility specialist for over 14 years, obstetrician and gynaecologist with over 25 years’ experience and a special interest in periconceptional medicine and anovulatory infertility.
Bronwyn counts many transgender patients and members of the LGBTQ+ community among her client success stories. She finds her job truly rewarding in the way it allows her to help create families in a variety of ways and she has developed a great deal of expertise in surrogacy and donor gametes.
Relatability and comfortability are crucial to Bronwyn’s bedside manner. For her, patients are best equipped to take this journey when they feel confident in having an open and honest dialogue about their medical history and fertility goals.
Her advice to couples thinking about booking a consult is to seek out an appropriate doctor who is not only specialised but clearly has their patients’ best interests at heart.
Nothing fills Bronwyn with more joy than the moment she is able to hand a new parent their newborn baby after going through IVF, especially so in cases where all hope had previously been lost.

Dr (Elizabeth) Emma Palmer is a Clinical Geneticist at Sydney Children’s Hospitals Network (SCHN) and university lecturer at the University of New South Wales, in Sydney Australia. She is passionate about improving the patient journey for all with rare genetic conditions and their families. Her work aims to improve the recognition of the possibility of genetic conditions by improving clinicain education about rare diseases, maximising the diagnostic yield of genetic tests and optimising patient care by linking families to best practice guidelines, treatments and supports. She has over 45 peer reviewed journal articles, including those describing 9 new genetic conditions.
She leads the following collaborative research programs:
1. Gene2Care, an innovative rare genetic disease program at SCHN, to ensure all families with genetic conditions have the option of participating in research and being linked to undiagnosed disease pathways and clinical trials.
2. GeneEQUAL a co-design project to improve equity and accessibility of genomic testing and counselling to people with intellectual disabilities and
3. CoGENES an interdisciplinary research team improving diagnoses, support and treatments for children with rare genetic epilepsies and their families, and
4. RArEST a collaborative project to improve awareness, education, training and support for rare disease across Australia.
She is also a chief investigator on many national and international rare disease programs including the newly launched national undiagnosed disease program UDN-Aus, the Australian Functional Genomic Network and the Diagnostic Working Group of the Undiagnosed Disease Network International.
She strives to ensure that the patient and family voice is always central to all her research.

Kate is a fertility specialist, gynaecologist and reproductive endocrinologist. She completed university in Melbourne and trained in obstetrics and gynaecology at The Women’s Hospital and The Mercy Hospital, with further work and experience in this field during two years in the UK.

Kate then spent three years specialising in infertility and reproductive endocrinology and is CREI qualified. She has led and participated in many research studies, both at Melbourne IVF and with other researchers. Kate has authored and co-authored over 45 research papers published in scientific journals.
She is Associate Professor of Obstetrics and Gynaecology at the University of Melbourne, Royal Women’s Hospital, and the Head of the Endocrine and Metabolic Service and Acting Head of Reproductive Services both at the Royal Women’s Hospital Melbourne. She is also the Clinical Director and Head of Clinical Research at Melbourne IVF.
Kate’s special interest is in medical fertility preservation and she established and coordinates the Fertility Preservation Services at the Royal Women’s Hospital and Melbourne IVF.
She currently co-chairs the COSA Medical Fertility Preservation Guidance development group and is also a member of the international Pancare working group for development of the European Fertility Preservation Guidelines.
Kate’s patients appreciate her accessibility and strong commitment to research guiding best practice. She is dedicated to ensuring every patient is given the best chance of having a family.